Morbidity and Mortality Weekly Report: Recommendations and Reports, December 30, 1994 / Vol. 43 / No. RR-15

Details

• Alternative Title:
  Prevention and Control of Influenza; Part II, Antiviral Agents : Recommendations of the Advisory Committee on Immunization Practices (ACIP)
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
• Personal Author:
  Arden, Nancy H. ; Cox, Nancy (Nancy J.) ; Schonberger, Lawrence B.
• Corporate Authors:
  Centers for Disease Control (U.S.), Immunization Practices Advisory Committee. ; Centers for Disease Control and Prevention (U.S.)
• Description:
  "These recommendations provide information about two antiviral agents: amantadine hydrochloride and rimantadine hydrochloride. These recommendations supersede MMWR 1992;41(No. RR-9). The primary changes include information about the recently licensed drug rimantadine, expanded information on the potential for adverse reactions to amantadine and rimantadine, and guidelines for the use of these drugs among certain persons." - p.1
• Subjects:
  Amantadine Antiviral Agents / Therapeutic Use Influenza, Human Influenza, Human / Drug Therapy Influenza, Human / Prevention & Control Rimantadine
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 1994; v. 43, no. 15
• Series:
  Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  1057-5987 (print)
• Document Type:
  Journal Issue
• Place as Subject:
  United States
• Pages in Document:
  17 pdf pages
• Volume:
  43
• Issue:
  15
• Collection(s):
  Guidelines and Recommendations Morbidity and Mortality Weekly Report (MMWR) Advisory Committee on Immunization Practices (ACIP)
• Main Document Checksum:
  urn:sha-512:22da3383ec3dd1117de1187938476d8fbe139ce0be2c8f50922e62a2f939a7aceb5fd0a5f86648498544a1b1089cb8dbdabbe332105f1bf8c08f4b58d6e57083
• Download URL:
  https://stacks.cdc.gov/view/cdc/5730/cdc_5730_DS1.pdf
• File Type:
  [PDF - 179.29 KB ]